A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice.
about
Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected miceImproved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boostingBCG-mediated protection against Mycobacterium ulcerans infection in the mouse.Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.Buruli ulcer.Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo.Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig ModelInterferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.Revisiting Buruli ulcer.FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with infection
P2860
Q28538249-85A8E59D-3C03-4538-8F45-A958D03DD2C2Q33324374-6C1AC20E-83EF-4941-90F7-BA2CFC3CF8FFQ33851427-30BACA7E-5547-426C-93C2-A5B6377B943FQ34193844-70975322-C6FC-4B77-9B42-D8C688063D34Q34229628-1086A9FF-C662-467D-9CBF-60615288128CQ34484489-A456DF9D-4A7B-4FA2-B794-4C15A8FED2B7Q34875651-F8D3AE8C-6943-436B-A122-1895266D2754Q35625819-E937DD5E-AF31-4B5F-B392-30FA5F668962Q35782951-C3F1D69E-B5DA-4905-ACE5-FCB7EE2EE42AQ35857386-7B417D1D-1D38-4558-AC52-E7A6DF664C96Q35919532-C02A6A31-6BD4-49B5-9418-FF907FA182F3Q38579126-6B7A7ADB-6CFF-4589-BE33-8654167251C5Q39215467-75DA559C-152A-42D8-A712-87AE803109A7Q46241939-E0609814-3274-4FFC-B8E8-6A8EE8AE3669Q58880192-AF467098-5567-4A16-8941-D9046D144CB6
P2860
A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A booster vaccination with Myc ...... um ulcerans infection in mice.
@en
A booster vaccination with Myc ...... um ulcerans infection in mice.
@nl
type
label
A booster vaccination with Myc ...... um ulcerans infection in mice.
@en
A booster vaccination with Myc ...... um ulcerans infection in mice.
@nl
prefLabel
A booster vaccination with Myc ...... um ulcerans infection in mice.
@en
A booster vaccination with Myc ...... um ulcerans infection in mice.
@nl
P2093
P2860
P356
P1476
A booster vaccination with Myc ...... um ulcerans infection in mice.
@en
P2093
Audrey Tanghe
Pierre-Yves Adnet
Tatiana Gartner
P2860
P304
P356
10.1128/IAI.01622-06
P407
P50
P577
2007-02-26T00:00:00Z